Text WHO Global Influenza Programme NIC Role during a pandemic and NIC contingency plan Wenqing Zhang MD Global Influenza Programme, WHO HQ THE 3rd MEETING.

Slides:



Advertisements
Similar presentations
Hospital Pandemic Influenza Planning by Ed Lydon, CVPH.
Advertisements

Vaccines & Antivirals: Provincial Stockpile & Distribution Plans Pandemic Planning Education Day for Community Laboratories Joanne Rey, Vaccine and Antiviral.
GOVERNMENT IMPACT AND PREPARATION. The United States Federal Government takes actions that are in the best interests of the nation and are not likely.
MINISTRY OF HEALTH ACTION PLAN FOR THE PREVENTION AND CONTROL OF ANTHRAX Dr. Marion BullockDuCasse, SMO(H) Director, Emergency, Disaster Management and.
JUNIADEE AHMAD (Acting) Chief Executive Officer Public Relation Division Ministry of Health Brunei Darussalam.
Wrap-up of Day 1. Plenary One: Regional and Global Update Update of global situation and response to pandemic (H1N1) Dr Wenqing Zhang Regional.
AUL Purpose The AUL is organized for support and cooperative purposes by its members. These purposes are: – To strengthen lab network in the USAPI countries.
1 Proposed Pharmacovigilance Plan for H5N1 Influenza Virus Vaccine Patrick Caubel, MD, PhD Head of Pharmacovigilance North America February 27, 2007.
Regional Health Focus Rome | 27 – 29 June |1 | Health Focus WHO Regional Perspective FAO/ OIE/ WHO Technical Meeting on Highly Pathogenic Avian.
Ebola Virus Disease Crisis in Western Africa Dr Marcos Espinal Director, Communicable Diseases and Health Analysis Washington DC, 24 September 2014.
1 Antivirals in the Draft CDC Pandemic Plan David K. Shay Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.
U.S. Pandemic Influenza Preparedness and Response: Planning and Activities “The pandemic influenza clock is ticking. We just don’t know what time it is.”
Role of the laboratory in disease surveillance
Pandemic Influenza Catherine Donovan, MD. MHSc. CIPHI, Newfoundland and Labrador, Oct 25, 2005 Eastern Region
1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.
Health System Response to Pandemic Influenza: A Clinician's Perspective Mary M. Klote, MD Walter Reed Army Medical Center.
Melissa House, Ph.D.: Public Health Walden University PUBH Instructor: Dr. Robert Marino Spring Qtr, 2011 D ISASTER P REPAREDNESS P ANDEMIC I NFLUENZA.
Pandemic Influenza Preparedness Kentucky Department for Public Health Department for Public Health.
The Quality Management System
Laboratory Training for Field Epidemiologists Strengthening Laboratory and Epidemiology Collaboration Introduction May 2007.
Influenza Surveillance at IRID Immunization and Respiratory Infections Division Centre for Infectious Disease Prevention & Control Public Health Agency.
Preparing for Winter 2010/11 Guidance Overview Stuart Low Planning Manager SG Health Delivery Directorate.
Progress Report Global Pandemic Preparedness Beijing Conference January 2006 Dr Margaret Chan Assistant Director-General Communicable Diseases Representative.
Raymond A. Strikas, MD Associate Director for Adult Immunization Immunization Services Division National Immunization Program Coordinating Center for Infectious.
(CAREC) PAHO/WHO Serving 21 Member Countries in the English and Dutch Speaking Caribbean Preparations for the Next Pandemic (or Epidemic or Outbreak) Leslie.
Stanislaus County It’s Not Flu as Usual It’s Not Flu as Usual Pandemic Influenza Preparedness Renee Cartier Emergency Preparedness Manager Health Services.
Surveillance Activities during Pandemic Phases Anne-Luise Winter APHEO-COMOH Workshop Toronto February 1, 2007.
Building Risk Communication Capacity for Emerging Infectious Diseases and Public Health Emergency , Lao PDR Presented by Khamphithoun Somsamouth,
1 WHO Communicable Diseases, Surveillance & Response SARS Diagnostics and Laboratory Needs: the WHO Perspective C.E. Roth Dangerous and New Pathogens Global.
Conclusions and Next steps Conclusions and Next steps EVD Preparedness Meeting: January 2015.
Health Security and Emergencies Ebola Response 13 October 2014.
Papua New Guinea Update 3 rd NIC Meeting 18 – 20 Beijing, China Berry Ropa National CSR Officer Department of Health Papua New Guinea.
World Health Organization, Regional Office for The Western Pacific Regional Activities Report and Preparation for the Upcoming Influenza Seasons THE 3rd.
Pandemic Response and current activities in Lao PDR NIC Meeting, Beijing, Aug 2009 Dr Phengta Vongphrachanh Director National centre for Laboratory.
Office of Public Health Preparedness and Response Division of Strategic National Stockpile Ben Erickson Public Health Analyst Inventory Management Tracking,
Laboratory Integration in Influenza Surveillance Dr Geethani Wickramasinghe NIC- Sri Lanka.
ASDPE Asia Pacific Strategy for Emerging Diseases (2010) and Influenza Activities Health Security and Emergencies (DSE) WHO Western Pacific Regional Office.
Result of gap analysis and framework of action required in coming five months August rd Meeting of National Influenza Centres in the Western.
US Situation Update and CDC International Response H1N1 Pandemic US Situation Update and CDC International Response Peter Nsubuga, MD, MPH On behalf of.
Mitigating the Impact of Pandemic (H1N1): Options for Public Health Measures Dr Li Ailan Communicable Disease Surveillance & Response (CSR) WHO Western.
PHEP Capabilities John Erickson, Special Assistant Washington State Department of Health
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
Communicable Disease Surveillance and Response, WHO Avian Influenza Credit: WHO Viet Nam.
Pandemic Preparedness Rome | June |1 | Pandemic Preparedness FAO/ OIE/ WHO Technical Meeting on Highly Pathogenic Avian Influenza, June,
Laboratory Results and Operations in WHO Phase 6 Dr. Attaporn Taweetungtragoon CYBELES Phnom Penh, Cambodia October 12-15, 2009.
Training structure Safety and good quality work Module 1: Knowledge about Ebola Virus Disease Support from the community Support from the hospital.
Group 2 Summary. Objective 1: Need for strengthening comprehensive national influenza surveillance systems 1) How have surveillance strategies changed?
1 |1 | Situation Update Influenza A (H1N1), 26 May 09.
UNCLASSIFIED As of W Mar 08 Mr. Scott A. Weidie, J722 1 Multinational Planning Augmentation Team (MPAT) 04 March 2008 Governments and Crises: Roles.
Conclusions 3 rd Meeting of National Influenza Centres in the Western Pacific and South East Asia Regions 18 – 20 August 2009 Beijing, China.
Wrap-up Day 2. Plenary Four: Pandemic and avian influenza updates Pandemic H1N1 – Origin of pandemic H1N1 virus – Genetically and antigenically homogenous.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
ASDPE International Health Regulations (IHR 2005) Laboratory and Zoonosis update Dr Richard Brown, WHO Thailand Workshop on Laboratory Diagnosis for Zoonotic.
EVD PREPAREDNESS UPDATE | FOR INTERNAL USE ONLY 1 |1 | Health Emergency Preparedness 12 January 2016.
AUSTRALIA. A National Strategy for Enhancing the Safety and Security of our Food Supply ที่มา : We pride ourselves on our high safety and security standards.
National Influenza Centres in SEA Region Dr Rajesh Bhatia / Dr Oommen John WHO Regional Office for South-East Asia New Delhi 5 th Meeting of NIC in Western.
ECDC role in public health crisis --- ECDC public health event operation plan Preparedness and response unit Improved co-ordination and support to response.
Ebola preparedness and Response in Lao PDR. Outline Objective The preparedness contingency plan Phase 1: Preparedness Phase 2: Contingency for response.
Pandemic Influenza: Planning and Preparedness Ben Schwartz, M.D. National Vaccine Program Office, U.S. Department of Health and Human Services NVAC Meeting,
ASDPE Regional Plan for Strengthening the National Influenza Surveillance Capacity: Guiding the way towards a comprehensive National Influenza Surveillance.
IHR Risk Communication Capacity Building Workshop Bryna Brennan, Senior Advisor, Risk and Outbreak Communication PAHO/WHO Lima, Peru – March 2010.
Current Pandemic H1N1 Updates in the Philippines Department of Health, Philippines Juan M. Lopez, MD, PGradDipPH, MPH Aldrin Q. Reyes, RN.
Session 2: Developing a Comprehensive M&E Work Plan.
Session 5: Selecting and Operationalizing Indicators.
Chapter 11: Nursing in Pandemics and Emergency Preparedness.
Influenza Virologic Surveillance and Vaccine Strain Selection Xiyan Xu MD Deputy Director WHO Collaborating Center for Surveillance, Epidemiology and Control.
Training structure EFFO Ebola Safety and good quality work
Overview of the Objectives, Expected Outcomes, and Meeting Agenda
The Role of NICs in Influenza Surveillance
Samia Metwally, DVM, PhD (FAO)
Presentation transcript:

text WHO Global Influenza Programme NIC Role during a pandemic and NIC contingency plan Wenqing Zhang MD Global Influenza Programme, WHO HQ THE 3rd MEETING OF NATIONAL INFLUENZA CENTRES IN THE WESTERN PACIFIC AND SOUTH EAST ASIA REGIONS August 2009 Beijing China

text 2 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 2 WHO Global Influenza Programme l NIC TOR – Stable for long-term, "glue" and "lubricant" of a Network Seasonal influenza surveillance and support to WHO vaccine virus process Detection of emerging virus – Minimum technical requirement to become a GISN member l NIC Role in monitoring and responding to the threat of human influenza – Precise roles of NICs during all the different stages of pandemic preparedness and response – WHO recommendation - implementation depending on national authorities – NOT to replace NIC TOR l NIC Contingency plan development guidance – Guidance to prepare for pandemic response l Laboratory surveillance and response guidelines during a pandemic – under development – Guidance to respond during a pandemic - A package for NICs - Key GISN documents related to NICs

text WHO Global Influenza Programme NIC role during a pandemic

text 4 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 4 WHO Global Influenza Programme Pandemic preparedness and response phases

text 5 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 5 WHO Global Influenza Programme Structure of recommendation of NIC role l Consistent with the WHO guidance: Pandemic Influenza Preparedness and Response – Planning and coordination – Situation monitoring and assessment – Reducing the spread of disease; and – Communications. l All recommended activities intended to continue in higher phases unless replaced

text 6 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 6 WHO Global Influenza Programme During a period of high alert – WHO phase 4 l Definitions – Phase 4: H-2-H transmission able to sustain at community-level Not necessarily mean a pandemic is to take place l NIC objectives – Early detection of novel virus infection in humans Geographically – assisting the decision making of rapid containment If rapid containment operation undertaken, enhanced surveillance in place – Assisting WHO and national authorities on: Pandemic risk assessment Development/update of vaccine viruses, diagnostics etc

text 7 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 7 WHO Global Influenza Programme l Planning and coordination – Affected countries Rapid containment –Whether or not to mount –If yes, assisting national authority an enhanced surveillance system Ensuring continuity of lab surveillance –Sampling strategy developed, reviewed, adjusted –Selection criteria developed jointly with WHO for sending representative specimens to CCs during rapid containment operation – All countries Implementation/adjustment of surge capacity plans Reviewing lab diagnostic strategy Be aware of and taking actions to any new WHO surveillance criteria Measures in place to protect lab workers During a period of high alert – WHO phase 4

text 8 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 8 WHO Global Influenza Programme l Situation monitoring and assessment – Affected countries Testing and sharing of specimens –Representative cases for testing: time sequential; symptom; geographical location; potential epi history … –Testing; characterization; alert to variant –Timely shipping all/selective specimens/virus isolates to WHO CCs Supporting the effective clinical management of infection –Continuing monitor susceptibility of antivirals to emerging virus strains –Rapid sharing of information significant of public health with WHO and national authorities – All countries Assistance to national authorities - systematically organizing specimen testing Advice to the country on lab testing algorithms and surveillance criteria Testing specimens from all suspected cases During a period of high alert – WHO phase 4

text 9 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 9 WHO Global Influenza Programme During a pandemic – WHO phases 5-6 l Definitions – Phase 5: novel virus established H-2-H transmission at community level in at least 2 countries in one WHO region – Phase 6: in addition, at least one other country in another WHO region l NIC objectives – Affected countries Assisting national authorities on mitigating pandemic impact Monitoring the evolution of the novel virus – Countries not yet affected Support detection of start of a pandemic to trigger interventions – All countries Assisting WHO and national authorities on: –Pandemic risk assessment –Development/update of vaccine viruses, diagnostics etc

text 10 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 10 WHO Global Influenza Programme During a pandemic – WHO phases 5-6 l Planning and coordination – Review lab components of national plan and implementation as required – Periodic review to sustain NIC diagnostic functioning – Adjustment of sampling/testing strategy – Be aware of update of guidance on biosafety requirements, specimen collection, storage and transport and selection of viruses to CCs

text 11 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 11 WHO Global Influenza Programme During a pandemic – WHO phases 5-6 l Situation monitoring and assessment – Affected countries Adjustment of lab surveillance from individual case diagnosis to overall monitoring Monitoring the percentages of novel virus and seasonal viruses co-circulating Adequate surveillance assist WHO/GISN monitoring antigenic evolution and antiviral susceptibility Timely sharing representative viruses/specimens with WHO Timely sharing findings of public health significance with WHO, national authorities and general public – Unaffected countries Update of plans/strategies developed based on gained experience from affected countries Maximizing surveillance for rapid detection of first cases

text 12 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 12 WHO Global Influenza Programme After a pandemic l Unknown of one wave or multiple waves l NIC objectives – Review and recovery Rebuilding NIC capacity, immediately Ready for "next" wave

text 13 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 13 WHO Global Influenza Programme After a pandemic l Post-peak period – Continuing virological surveillance to support WHO on: Percentage of novel virus detections among all influenza virus circulating Vaccine virus update Antiviral susceptibility Diagnostics update Pandemic risk assessment – Capacity restore – Gap/lesson/experience review – Possible research studies l Possible new wave – Same as that for phases 5-6

text 14 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 14 WHO Global Influenza Programme After a pandemic l Post-pandemic period – Same as that for post-peak period In particular on the proportions of circulating influenza viruses – which will become seasonal influenza viruses …

text 15 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 15 WHO Global Influenza Programme Summary – NIC role l NICs most likely the primary source of expertise in surveillance and response to influenza epidemics and pandemics l Triggering many of the well-planned interventions depending on NICs' effective functioning – Proved by the recent H1N1 event l GISN – WHO coordinated efforts on laboratory/virological surveillance, preparedness and response – Significant contribution to response to routine and emerging influenza problem – NICs are the backbone l NIC role in all different phases interlinked l Influenza, at its core, a virus problem – Respect to science and nature – Working as a team globally l Science and knowledge – key to success

text WHO Global Influenza Programme NIC contingency plan

text 17 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 17 WHO Global Influenza Programme Why a NIC contingency plan l Lab response/service - a key and indispensible component of overall national/global response l Significantly increased level of demand for lab service expected – … and proved by recent response – Most likely exceed routine NIC operations l Ensuring effectiveness and continuity of NIC functioning – Political and institutional commitment needed – Coordination from high-level e.g. from MoH l Need planning in advance

text 18 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 18 WHO Global Influenza Programme How to develop a NIC contingency plan l Assessment on anticipated surge level that will be put on the NIC l Identification of the actions and resources needed to establish and maintain the required "surge capacity" – Ensuring the availability of premises, staff and equipment – Stockpiling supplies – Testing strategies, protocols and algorithms – Lab biosafety and transport of specimens – Data management – Communication

text 19 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 19 WHO Global Influenza Programme Ensuring the availability of premises, staff and equipment l Availability of lab and office space – Extra lab and office needed during a pandemic Helpful to transfer lab diagnostic technologies to other labs – Additional freezer space needed during a pandemic – If BSL3 lab available, priority reserved for flu-related work l Availability of trained staff – Adequate training in advance – Engaging workers in other labs possibly – Less-well-trained staff could assist with task e.g. tracking specimens, preparing specimen collection kits etc – NIC to keep a full list of available staff and their relevant training – A plan of work shifts and backup personnel in place – Medical surveillance plan in place l Equipment – Should have a back-up power source – Other back-up equipment e.g. biosafety cabinet, PCR machines, incubators either purchased in advance or sourced from other labs – Increased storage capacity – NIC to keep an updated inventory of all lab equipment

text 20 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 20 WHO Global Influenza Programme Stockpiling supplies l Stockpiling reagents – Not all have long shelf life, and delivery of supplies might be long lead- time – In general, a stockpile sufficient for at least 3 months of current NIC activity could be a good strategy – NICs may wish to establish networks and reach agreement on the exchange of reagents in order to meet short needs l Stockpiling of/access to antiviral drugs – In coordination with MoH/occupational health l Stockpiling of PPE

text 21 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 21 WHO Global Influenza Programme Testing strategies, protocols and algorithms l Testing strategy – should be based on national strategies for pandemic surveillance and the capabilities and resources of the lab – Lead-up and early stages, every specimens to be tested – While virus widespread, selection criteria for specimens to be tested should be established and applied l Testing protocols – Each protocols must be thoroughly validated before being put into routine use – To be agreed upon with epidemiologists and network members l Testing algorithms – In line with national and global pandemic surveillance strategies

text 22 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 22 WHO Global Influenza Programme Laboratory biosafety and transport of specimens l Lab biosafety and biosecurity – Biosafety cabinet – Understanding and training on practice at appropriate biosafety levels – Seasonal vaccination among lab workers l Transport of specimens in-country – Possible disruption of or refusal by routine transport system – SOP in place with coordination from high level national authorities l Transport of specimens to reference labs and WHO CCs – WHO guidelines on specimens/virus shipping followed – International transport arranged according to IATA regulations – Import/export permits obtained in advance – Personnel handling shipping trained

text 23 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 23 WHO Global Influenza Programme Data management l Conventional filing of forms and results – At the very minimum and essential – and be maintained to provide back-up if electronic systems down l Electronic systems – Best use existing systems to avoid additional duplicated work – As simple as possible to keep key information – Remaining possibility to expand the system

text 24 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 24 WHO Global Influenza Programme Communications l Successful NIC response has to be team work l A robust communication network established in advance – MoH, national lab network, WHO, WHO CCs, NICs, other partners l GISN communication platform for timely and informal communications l FluNet reporting – lab surveillance findings

text 25 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 25 WHO Global Influenza Programme Summary – NIC contingency plan l Lab surge capacity is anticipated and inevitable l The better planned/prepared, – the less chaos in a lab handling pouring in specimens and under pressing stress – the better continuity of NIC quality service l Individual NICs individual plans l Commitments from MoH and host institution is key l "NIC contingency plan" not just another document – Reassurance to success of national and global pandemic response – Protection of NIC staff – precious asset of a country l Take actions!

text 26 Epidemic and Pandemic Alert and Response - WHO Global Influenza Programme text 26 WHO Global Influenza Programme